Brynjar Viðarsson

1.2k total citations
21 papers, 286 citations indexed

About

Brynjar Viðarsson is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Brynjar Viðarsson has authored 21 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Brynjar Viðarsson's work include Chronic Lymphocytic Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Brynjar Viðarsson is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Brynjar Viðarsson collaborates with scholars based in Iceland, United States and Denmark. Brynjar Viðarsson's co-authors include Páll T. Önundarson, Deane F. Mosher, Árni Jón Geirsson, Timothy Woods, Helgi J. Ísaksson, James H. Stein, M. Shahriar Salamat, Brynja R. Guðmundsdóttir, Magnús K. Magnússon and Bjarni A. Agnarsson and has published in prestigious journals such as Blood, The American Journal of Medicine and Thrombosis and Haemostasis.

In The Last Decade

Brynjar Viðarsson

17 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brynjar Viðarsson Iceland 9 142 60 55 37 36 21 286
Virginie Barbay France 9 87 0.6× 86 1.4× 25 0.5× 17 0.5× 16 0.4× 22 235
Emilio Pastor Spain 10 151 1.1× 79 1.3× 35 0.6× 21 0.6× 25 0.7× 26 317
Christophe Bovy Belgium 10 86 0.6× 23 0.4× 73 1.3× 19 0.5× 35 1.0× 29 275
Georgia Kaiafa Greece 8 84 0.6× 24 0.4× 79 1.4× 32 0.9× 20 0.6× 23 281
Sandra Le Quellec France 10 247 1.7× 77 1.3× 64 1.2× 39 1.1× 20 0.6× 31 385
Andrew Hodgson Ireland 7 195 1.4× 41 0.7× 27 0.5× 14 0.4× 18 0.5× 13 374
Krzysztof Karnicki United States 11 171 1.2× 103 1.7× 17 0.3× 22 0.6× 42 1.2× 21 418
Alessandro Brunetti Italy 11 261 1.8× 25 0.4× 76 1.4× 13 0.4× 84 2.3× 41 400
Erin Jamula Canada 8 67 0.5× 140 2.3× 32 0.6× 9 0.2× 29 0.8× 24 311
Noelia Sastre Spain 8 86 0.6× 14 0.2× 176 3.2× 38 1.0× 46 1.3× 12 351

Countries citing papers authored by Brynjar Viðarsson

Since Specialization
Citations

This map shows the geographic impact of Brynjar Viðarsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brynjar Viðarsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brynjar Viðarsson more than expected).

Fields of papers citing papers by Brynjar Viðarsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brynjar Viðarsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brynjar Viðarsson. The network helps show where Brynjar Viðarsson may publish in the future.

Co-authorship network of co-authors of Brynjar Viðarsson

This figure shows the co-authorship network connecting the top 25 collaborators of Brynjar Viðarsson. A scholar is included among the top collaborators of Brynjar Viðarsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brynjar Viðarsson. Brynjar Viðarsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rögnvaldsson, Sæmundur, Jon Oskarsson, Malin Hultcrantz, et al.. (2024). Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population‐based screening study. HemaSphere. 8(11). e70046–e70046.
2.
Rögnvaldsson, Sæmundur, Sigrún Þorsteinsdóttir, Þórir Einarsson Long, et al.. (2024). The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance: a flow cytometry sub-study of the iStopMM screening study. Blood Cancer Journal. 14(1). 221–221. 2 indexed citations
3.
Lund, Sigrún H., Saedís Saevarsdóttir, Brynjar Viðarsson, et al.. (2023). Phenotypes Associated with HFE p.C282Y Homozygosity, the Main Hereditary Hemochromatosis Genotype, in Four Large Genetic Cohorts. Blood. 142(Supplement 1). 1088–1088.
4.
Rögnvaldsson, Sæmundur, Sigrún Þorsteinsdóttir, Brynjar Viðarsson, et al.. (2023). Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study. Haematologica. 108(12). 3392–3398. 13 indexed citations
5.
Viðarsson, Brynjar, et al.. (2020). A comparison of platelet quality between platelets from healthy donors and hereditary hemochromatosis donors over seven‐day storage. Transfusion. 61(1). 202–211. 3 indexed citations
6.
Guðmundsdóttir, Brynja R., Ólafur S. Indridason, Sigrún H. Lund, et al.. (2017). Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial. Journal of Thrombosis and Thrombolysis. 43(4). 550–561. 8 indexed citations
7.
Steingrímsdóttir, Hlíf, et al.. (2016). Langvinnt eitilfrumuhvítblæði á Íslandi árin 2003-2013: Nýgengi, aðdragandi greiningar og undanfari. Læknablaðið. 2016(4). 171–177. 1 indexed citations
8.
Önundarson, Páll T., Charles W. Francis, Ólafur S. Indridason, et al.. (2015). Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial. The Lancet Haematology. 2(6). e231–e240. 22 indexed citations
9.
Guðmundsdóttir, Brynja R., Bylgja Hilmarsdóttir, Brynjar Viðarsson, et al.. (2014). Clinical phenotype in heterozygote and biallelic Bernard‐Soulier syndrome—A case control study. American Journal of Hematology. 90(2). 149–155. 19 indexed citations
10.
Pálsson, Ragnar, Brynjar Viðarsson, Brynja R. Guðmundsdóttir, et al.. (2013). Complementary effect of fibrinogen and rFVIIa on clottingex vivoin Bernard-Soulier syndrome and combined use during three deliveries. Platelets. 25(5). 357–362. 7 indexed citations
11.
Viðarsson, Brynjar, Kristinn Sigvaldason, Johann P. Ingimarsson, et al.. (2012). Recombinant factor VIIa as last‐resort treatment of desperate haemorrhage. Acta Anaesthesiologica Scandinavica. 56(5). 636–644. 8 indexed citations
12.
Ásgeirsson, Hilmir, et al.. (2010). Bráðir kviðverkir af völdum slitróttrar bráðaporfýríu - sjúkratilfelli og yfirlit. Læknablaðið. 2010(6). 413–418.
13.
Ingimarsson, Johann P., Páll T. Önundarson, Felix Valsson, Brynjar Viðarsson, & Tómas Guðbjartsson. (2008). [The use of recombinant activated factor VIIa for major bleedings in open heart surgery].. PubMed. 94(9). 607–12. 1 indexed citations
14.
Viðarsson, Brynjar, et al.. (2002). Mesenteric Panniculitis Presenting with Autoimmune Haemolytic Anaemia. Acta Haematologica. 107(1). 35–37. 7 indexed citations
15.
Viðarsson, Brynjar, Deane F. Mosher, M. Shahriar Salamat, Helgi J. Ísaksson, & Páll T. Önundarson. (2002). Progressive multifocal leukoencephalopathy after fludarabine therapy for low‐grade lymphoproliferative disease. American Journal of Hematology. 70(1). 51–54. 33 indexed citations
16.
Kristinsson, Sigurður Y., Brynjar Viðarsson, Bjarni A. Agnarsson, et al.. (2002). Epidemiology of hairy cell leukemia in Iceland. The Hematology Journal. 3(3). 145–147. 10 indexed citations
17.
Viðarsson, Brynjar, Rafat Abonour, Eliot C. Williams, et al.. (2001). Fludarabine and Cytarabine as a Sequential Infusion Regimen for Treatment of Adults with Recurrent, Refractory or Poor Prognosis Acute Leukemia. Leukemia & lymphoma. 41(3-4). 321–331. 13 indexed citations
18.
Viðarsson, Brynjar & Páll T. Önundarson. (2000). Recombinant Factor VIIa for Bleeding in Refractory Thrombocytopenia. Thrombosis and Haemostasis. 83(4). 634–635. 70 indexed citations
19.
Woods, Timothy, Brynjar Viðarsson, Deane F. Mosher, & James H. Stein. (1999). Transient effusive‐constrictive pericarditis due to chemotherapy. Clinical Cardiology. 22(4). 316–318. 28 indexed citations
20.
Viðarsson, Brynjar, Árni Jón Geirsson, & Páll T. Önundarson. (1995). Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for felty's syndrome. The American Journal of Medicine. 98(6). 589–591. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginie Barbay Breakdown of academic impact, for papers by Emilio Pastor Breakdown of academic impact, for papers by Christophe Bovy Breakdown of academic impact, for papers by Georgia Kaiafa Breakdown of academic impact, for papers by Sandra Le Quellec Breakdown of academic impact, for papers by Andrew Hodgson Breakdown of academic impact, for papers by Krzysztof Karnicki Breakdown of academic impact, for papers by Alessandro Brunetti Breakdown of academic impact, for papers by Erin Jamula Breakdown of academic impact, for papers by Noelia Sastre
Rankless by CCL
2026